AstraZeneca’s CEO on competing in the new world order
AstraZeneca’s CEO, a French-born Australian running an Anglo-Swedish company, is betting $50 billion on a strategy of making the US its largest market — while also pouring $15 billion into China. Each of the time zones Pascal Soriot operates in has offered …